Generation of the first autosomal dominant osteopetrosis type II (ADO2) disease models

被引:32
|
作者
Alam, Imranul [1 ]
Gray, Amie K. [2 ]
Chu, Kang [2 ]
Ichikawa, Shoji [2 ]
Mohammad, Khalid S. [2 ]
Capannolo, Marta [4 ]
Capulli, Mattia [4 ]
Maurizi, Antonio [4 ]
Muraca, Maurizio [5 ]
Teti, Anna [4 ]
Econs, Michael J. [2 ,3 ]
Del Fattore, Andrea [5 ]
机构
[1] Indiana Univ, Dept Orthoped Surg, Indianapolis, IN 46202 USA
[2] Indiana Univ, Dept Med, Indianapolis, IN 46202 USA
[3] Indiana Univ, Dept Med & Mol Genet, Indianapolis, IN 46202 USA
[4] Univ Aquila, Dept Biotechnol & Appl Clin Sci, I-67100 Laquila, Italy
[5] Bambino Gesu Pediat Hosp, Regenerat Med Unit, Ist Ricovero Cura Carattere Sci, I-00165 Rome, Italy
关键词
Osteopetrosis; Autosomal dominant osteopetrosis; Osteoclast; Chloride channel 7; Mouse model; ALBERS-SCHONBERG-DISEASE; CHLORIDE CHANNEL; MUTATIONS; CLC-7; BIOLOGY; CIC-7; LEADS; GENE;
D O I
10.1016/j.bone.2013.10.021
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Autosomal dominant osteopetrosis type II (ADO2) is a heritable osteosclerotic disorder dependent on osteoclast impairment. In most patients it results from heterozygous missense mutations in the chloride channel 7 (CLCN7) gene, encoding for a 2Cl(-)/1H(+) antiporter. By a knock-in strategy inserting a missense mutation in the Clcn7 gene, our two research groups independently generated mouse models of ADO2 on different genetic backgrounds carrying the homolog of the most frequent heterozygous mutation (p.G213R) in the Clcn7 gene found in humans. Our results demonstrate that the heterozygous model holds true presenting with higher bone mass, increased numbers of poorly resorbing osteoclasts and a lethal phenotype in the homozygous state. Considerable variability is observed in the heterozygous mice according with the mouse background, suggesting that modifier genes could influence the penetrance of the disease gene. (C) 2013 Elsevier Inc. All rights reserved.
引用
收藏
页码:66 / 75
页数:10
相关论文
共 50 条
  • [1] Establishment of a first conditional knock in mice as a disease model for autosomal dominant osteopetrosis type II (ADO2)
    Lv, Shanshan
    Zhang, Zhenlin
    Wang, Chun
    JOURNAL OF BONE AND MINERAL RESEARCH, 2019, 34 : 274 - 275
  • [2] GENERATION OF THE FIRST MOUSE MODEL OF AUTOSOMAL DOMINANT TYPE II OSTEOPETROSIS (ADO2) HARBOURING THE PG213R-CLC7 MUTATION
    Del Fattore, A.
    Gray, A. K.
    Ichikawa, S.
    Chu, K.
    Mohammad, K. S.
    Capannolo, M.
    Muraca, M.
    Teti, A.
    Econs, M. J.
    Alam, I.
    OSTEOPOROSIS INTERNATIONAL, 2013, 24 : S220 - S220
  • [3] Phenotypic severity of autosomal dominant osteopetrosis type II (ADO2) mice on different genetic backgrounds recapitulates the features of human disease
    Alam, Imranul
    McQueen, Arnie K.
    Acton, Dena
    Reilly, Austin M.
    Gerard-O'Riley, Rita L.
    Oakes, Dana K.
    Kasipathi, Charishma
    Huffer, Abigail
    Wright, Weston B.
    Econs, Michael J.
    BONE, 2017, 94 : 34 - 41
  • [4] Efficacy of an Experimental small interfering RNA Therapy for Autosomal Dominant Osteopetrosis type 2 (ADO2)
    Capulli, Mattia
    Maurizi, Antonio
    Rucci, Nadia
    Teti, Anna
    JOURNAL OF BONE AND MINERAL RESEARCH, 2014, 29 : S38 - S38
  • [5] CLCN7-dependent Autosomal Dominant Osteopetrosis type 2 (ADO2): more than a bone disease.
    Maurizi, Antonio
    Capulli, Mattia
    Patel, Rajvi
    Cortes, Juliana
    Rucci, Nadia
    Teti, Anna
    JOURNAL OF BONE AND MINERAL RESEARCH, 2017, 32 : S395 - S395
  • [6] Clinical characteristics of 94 subjects with autosomal dominant osteopetrosis type II (ADO2) and chloride channel 7 gene mutations.
    Waguespack, SG
    Buckwalter, KA
    Econs, MJ
    JOURNAL OF BONE AND MINERAL RESEARCH, 2003, 18 : S43 - S43
  • [7] Insertion of the clcn7 gene mutation pG213R in mouse induces autosomal dominant osteopetrosis type II (ADO2)
    Del Fattore, A.
    Gray, A. K.
    Ichikawa, S.
    Chu, K.
    Mohammad, K. S.
    Capannolo, M.
    Teti, A.
    Econs, M. J.
    Alam, I.
    BONE, 2012, 51 (06) : S14 - S14
  • [8] Autosomal Dominant Osteopetrosis Type II
    Lin, Hsuan-Ming
    Chang, Chiz-Tzung
    Huang, Chiu-Ching
    INTERNAL MEDICINE, 2011, 50 (21) : 2695 - 2696
  • [9] Type II autosomal dominant osteopetrosis
    Senel, K
    Ugur, M
    Erdal, A
    Özdemir, H
    RHEUMATOLOGY INTERNATIONAL, 2002, 22 (03) : 116 - 118
  • [10] Type II autosomal dominant osteopetrosis
    Kazim Senel
    Mahir Ugur
    Akin Erdal
    Hasan Özdemir
    Rheumatology International, 2002, 22 : 116 - 118